Background
Oral candidiasis is the most prevalent oral fungal infection, and existing antifungal agents have side effects such as drug intolerance, resistance, and toxicity. Herbal essential oils are emerging as an alternative therapeutic approach for treating fungal infections
.
Origanum vulgare
(
O. vulgare
), commonly known as oregano, and
Syzygium aromaticum
(
S. aromaticum
), commonly known as clove, are known to have antifungal properties and are effective against fluconazole-resistant strains. A combination of essential oils has a synergistic effect and aids in achieving effective antifungal activity at sufficiently low concentrations, which could lead to reduced side effects and resistance.
Aim of the study
This study aimed to formulate and develop an herbal antifungal gel containing
O. vulgare
and
S. aromaticum
and evaluate its synergistic antifungal efficacy against oral
Candida albicans
(
C. albicans).
Methodology
Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) determinations of
O. vulgare
and
S. aromaticum
essential oils were performed individually and in combination to assess the antifungal activity against
C. albicans.
Based on the obtained MIC and MFC of essential oils in combination
,
an herbal antifungal gel was formulated. Further, to determine the biocompatible nature of the gel, a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed.
Results
We found that a combination of
O. vulgare
and
S. aromaticum
essential oils showed antifungal activity at a lesser concentration, with a MIC of 0.19
μ
l/ml and MFC of 0.39
μ
l/ml when compared to their individual concentrations. Based on our results, an antifungal herbal gel comprising a concentration of 0.6
μ
l/ml of both essential oils was developed to achieve synergistic antifungal activity against oral
C. albicans.
The MTT assay of the herbal gel did not show any cytotoxicity.
Conclusion
The novel herbal antifungal gel containing
O. vulgare
and
S. aromaticum
is biocompatible in nature and provides an alternative therapeutic approach for treating oral candidiasis.